Why NAD+ Supplements Are a Waste of Money

Your NAD+ levels are not low because your body stopped making enough. They are low because something is burning through it faster than your body can replace it, and understanding that difference changes everything about how you should approach this problem.

To understand why, you need the full picture first.

NAD+ is something called a coenzyme, which is a molecule that powers the enzymes responsible for energy production, DNA repair, and cellular maintenance throughout your body. As you age, NAD+ levels drop significantly, and the research is clear that this decline is connected to many of the things we associate with aging. The supplement industry saw that connection and built a multi-billion dollar market around one simple idea: if NAD+ is low, take NAD+. But that reasoning skips over the actual mechanism, and skipping the mechanism is why it does not work.

Here is the full chain you need to understand before any of the details make sense.

As your body accumulates damage over decades, some cells enter a state called senescence, which means they have stopped dividing but have not been cleared out the way they should be. Those senescent cells release a steady stream of inflammatory signals. Those signals recruit immune cells, particularly macrophages, which upregulate an enzyme called CD38. CD38 then burns through NAD+ to produce the signaling molecules the immune system needs to manage all that ongoing damage. The more senescent cells you have, the more inflammation, the more CD38 activity, the faster NAD+ disappears. That is the chain.

Now zoom in on CD38, because this is where the data gets specific.

Research published in Cell Metabolism found that CD38 activity increases two to three fold across all tissues as you age, and that this increase is almost perfectly inversely correlated with NAD+ levels. When they removed CD38 from mice entirely, NAD+ levels stayed constant at every age. Not slightly better. Constant. That result tells you something direct: the body was not producing less NAD+, it was losing it to a single enzyme that should not have been that active.

The follow-up work published in Nature Metabolism traced exactly why CD38 gets so elevated. Senescent cells secrete inflammatory cytokines that cause nearby macrophages to upregulate CD38 expression by up to 600 fold. That is not a typo. 600 fold. The causal chain runs from accumulated senescent cells, to inflammatory signaling, to macrophage activation, to CD38 overexpression, to NAD+ depletion. Supplementing NAD+ precursors at the end of that chain does not address any of the steps before it.

Damaged mitochondria make the problem worse through a second pathway.

When mitochondria accumulate structural damage, they activate a class of repair enzymes called PARPs, which stands for poly ADP-ribose polymerases, and these enzymes use NAD+ as their fuel source. So you now have two major drains running simultaneously: CD38 burning NAD+ in response to immune signaling, and PARPs burning NAD+ trying to repair mitochondrial damage. Taking a precursor supplement into that situation is like pouring water into a bathtub with two open drains. The tub never fills. You just add water.

This is exactly why the human research on NMN and NR supplements has been so underwhelming despite the excitement around them. A review of 25 human trials of nicotinamide riboside concluded there is an unfortunate tendency in the literature to exaggerate the importance and robustness of reported effects. And there is a separate absorption problem layered on top of the efficacy problem: research published in FEBS Letters found that gut bacteria convert NMN to niacin before it is even absorbed, meaning most of what you are buying in an expensive NMN capsule arrives in your bloodstream as plain niacin anyway, which costs pennies.

So if supplementing precursors does not address the drain, what does?

The first intervention is exercise, and the mechanism matters here. Exercise increases the expression of something called NAMPT, which is the enzyme that recycles NAD+ back from its depleted form. A systematic review with meta-analysis found that exercise training increases NAMPT expression by over 127% with a large effect size. That is your body's internal recycling system running faster, which reduces how much new NAD+ needs to be generated in the first place.

The second intervention addresses the mitochondrial drain directly. A peptide called SS-31 works by binding to a specific lipid in the inner mitochondrial membrane called cardiolipin, which stabilizes the membrane structure and reduces the oxidative damage that drives PARP activation. In aged mouse hearts, research in Aging Cell found that neither SS-31 nor NMN alone significantly increased resting NAD levels. Only the combination did. That result shows that mitochondrial repair has to come first before precursor support can do anything meaningful.

The third intervention addresses the upstream source of the whole problem: the senescent cells driving CD38 activity. A peptide called FOXO4-DRI is designed to selectively trigger apoptosis in senescent cells, which means it causes the cells that should have cleared out to finally do so. Fewer senescent cells means less inflammatory signaling, which means less CD38 upregulation, which means the drain slows down. This is the furthest upstream intervention available, and the research is still early in humans, so it warrants appropriate caution. But the logic of the mechanism follows directly from the cell metabolism data.

Once you address the drains, and only then, adding a precursor like niacin makes sense. At that point you are filling a bathtub where someone has finally closed the drains. Before that, you are just running up a supplement bill.

Most NAD+ marketing works by showing you a real problem, declining NAD+ with age, and then selling you the solution that is easiest to package and ship. The actual problem is upstream. The decline is a symptom of a system under chronic demand, not a system that forgot how to produce. Treating a supply problem you do not have while ignoring the consumption problem you do have is not just ineffective. It is a way of staying busy while the underlying damage continues.

---

References

1. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across all tissues, with near-perfect inverse correlation to NAD+ levels. CD38 knockout mice maintained NAD+ at all ages. Source
2. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cells secrete inflammatory cytokines that cause macrophages to upregulate CD38 expression up to 600-fold, establishing the causal chain from cellular senescence to NAD+ decline. Source
3. Kim LJ, Chalmers TJ, Madawala R, et al. Host-microbiome interactions in nicotinamide mononucleotide NMN deamidation. FEBS Letters. 2023;59717:2196-2207. Finding: Gut bacteria deamidate NMN before absorption, converting it to nicotinic acid niacin. Ablation of microbiome with antibiotics increased direct NMN uptake, confirming gut conversion. Source
4. Science Advances enterohepatic circulation study. Finding: NMN and NR facilitate NAD+ synthesis primarily through conversion to niacin-pathway metabolites in the gut, confirming that most oral precursors become niacin before absorption. Source
5. Sun X, Su L, Bu T, Zhang Y. Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis. Frontiers in Public Health. 2023;11:1287421. Finding: Exercise training increases NAMPT expression by over 127% with a large effect size Cohen's d = 0.81. Source
6. Whitson JA, Martin SS, Zhang H, et al. SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020;1910:e13213. Finding: Neither SS-31 nor NMN alone significantly increased resting NADH levels in aged mouse hearts. Only the combination did, best recapitulating the young state. Source
7. Brakedal B, Doring A, Riber C, et al. What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances. 2023;929:eadi4862. Finding: Review of 25 NR human studies concluded there is "an unfortunate tendency in the literature to exaggerate" the importance and robustness of reported effects. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness